Find out how efficient Asia’s healthcare system is with Prof Himanshu Rai at the Indian Institute of Management Indore ...

Hyderabad: Home to Genome Valley, Hyderabad has emerged as one of the top life sciences clusters not just in India and Asia ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

Operations: The company generates revenue primarily from its biotechnology segment ... ALTEOGEN favorably within the high-growth tech sector in Asia. The company's commitment to innovation ...

I’m grateful to have experts in US policy and Asia’s economic ... security concerns related to biotech, particularly with China's increasing influence in this sector. According to Tong ...

Novotech is a winner in the Diversity, Research and Development, and Marketing categories in the 2025 Pharmaceutical ...

positioning ALTEOGEN favorably within the high-growth tech sector in Asia. The company's commitment to innovation is evident from its R&D spending trends, which are crucial for sustaining its rapid ...

Biowave will address this lackluster entrepreneurial activity and bring more VC investment into India’s life sciences.

The potential for Asia’s SAF industry is such that it could play ... was completed in 2024 by Henan Junheng Industrial Group Biotechnology Co. in Henan Province. Many other SAF initiatives ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug deve ...

Largest Series A financing round in Asia's diagnostic technology sector since 2019 underscores strong investor confidence in PHASE Scientific's breakthrough diagnostic technology and growth vision.

Hyderabad emerges as one of the top global centres of life sciences manufacturing: CBRE report: Our Bureau, Bengaluru Wednesday, May 14, 2025, 14:15 Hrs [IST] CBRE, world’s lead ...